Advances in nanotheranostics II : cancer theranostic nanomedicine /: cancer theranostic nanomedicine. ([2016])

• Record Type: Book
• Further Information: Note: Zhifei Dai, editor.
• Editors: Dai, Zhifei
• Contents: Preface; Contents; Contributors; Part I: Magnetic Nanoparticles for MRI-Based Theranostics; Chapter 1: Design of Magnetic Nanoparticles for MRI-­Based Theranostics; 1.1 Introduction; 1.1.1 The Principle of MRI; 1.1.2 The MRI Contrast Agents; 1.2 Chemical Preparation of MNPs for MRI Contrast Agents; 1.2.1 Coprecipitation Method; 1.2.2 Polyol Process; 1.2.3 Ultrasonic Chemical Method; 1.2.4 Soft Template Synthesis Method; 1.2.5 Thermal Decomposition Method; 1.2.6 Solvothermal Method; 1.3 Nano Contrast Agents for MRI; 1.3.1 T1 Nano Contrast Agents; 1.3.2 T2 Nano Contrast Agents. 1.4 Multifunctionalization and Application of MNPs as MRI Contrast Agents1.4.1 Multifunctionalization Methods; 1.4.1.1 Ligand Exchange or Adsorption of Organic Molecules; 1.4.1.2 Polymer Coating; 1.4.1.3 Silica Coating; 1.4.1.4 Liposome and Micelle Encapsulation; 1.4.2 Theranostic Applications of MRI-Based MNPs; 1.4.2.1 Magnetic Targeting Therapy; 1.4.2.2 Magnetic Controlling Drug Delivery; 1.4.2.3 Magnetic Hyperthermia; 1.4.2.4 Cell Fate Controlling by Magnetic Field; 1.5 Conclusions and Outlook; References. Chapter 2: Controlled Synthesis and Surface Modification of Magnetic Nanoparticles with High Performance for Cancer Theranostics Combining Targeted MR Imaging and Hyperthermia2.1 Controlled Synthesis and Surface Modification of MNPs with High Performance; 2.1.1 Conventional Synthesis of MNPs; 2.1.2 Advantage of Synthesis of High-Quality MNPs by Thermal Decomposition; 2.1.2.1 Formation Mechanism of Monodisperse MNPs by Thermal Decomposition; 2.1.2.2 Size Effects; 2.1.2.3 Shape Effects: From 0-D Nanocrystals to 3-D Nanoclusters; 2.1.2.4 Magnetic Metal-Dopant Effects; 2.1.2.5 Metal Alloy. 3.5.1 Imaging with Gd(III)-Containing Contrast Agents3.5.2 Imaging with Superparamagnetic Iron Oxide (SPIO) Nanoparticles; 3.5.3 Imaging with Dual-Targeting Probes; 3.5.4 Biological Effects of RGD Peptide-Conjugated Probes on Tumor Cells; 3.6 Summary and Future Perspectives; References; Part II: Ultrasonic Theranostic Agents; Chapter 4: Multifunctional Ultrasound Contrast Agents Integrating Targeted Imaging and Therapy; 4.1 Introduction; 4.2 General Design of Ultrasound Contrast Agents; 4.2.1 Requirements of an Ideal Ultrasound Contrast Agent.
• Publisher Details: Singapore : Springer
• Publication Date: 2016
• Copyright Date: 2016
• Extent: 1 online resource (xi, 336 pages), illustrations (some color)
• Subjects: 610.28; Nanomedicine; Nanostructured materials; Nanomedicine; Nanostructured materials; HEALTH & FITNESS / Holism; HEALTH & FITNESS / Reference; MEDICAL / Alternative Medicine; MEDICAL / Atlases; MEDICAL / Essays; MEDICAL / Family & General Practice; MEDICAL / Holistic Medicine; MEDICAL / Osteopathy; Engineering; Biomedical Engineering; Nanotechnology; Imaging / Radiology; Biomaterials; Oncology; Nanostructures; Electronic books; Electronic books; Electronic books
• Languages: English
• ISBNs: 9789811000638; 9811000638
• Related ISBNs: 9789811000614; 9811000611
• Notes: Note: Online resource; title from PDF title page (SpringerLink, viewed January 19, 2016).
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.